SRS tumour targeting for patients in the East Midlands

Clinical nurse specialist Rebecca Bentley, SRS lead radiographer Rachel Clements, consultant clinical oncologist Dr Luis Aznar-Garcia, IGRT lead radiographer Suzanne Jordan, SRS lead physicist Anna Bangiri and radiotherapy services manager Russell Hart.

Nottingham University Hospitals (NUH) is the first trust in the UK to have installed pioneering equipment to enable patients in the East Midlands to benefit from stereotactic radiotherapy/surgery (SRS) brain tumour treatment.

Head of radiotherapy physics at NUH Dr Keith Langmack said: “The technology used in SRS delivers extremely accurate directed beams of radiation to the target site, meaning that there is less risk of damage to surrounding healthy tissue and fewer side effects for patients.  The new combinational kit enables us to provide sub-millimetre precision for targeted radiotherapy treatment.  The entire procedure can take around 40 minutes, treating up to three tumours in one session.”

The linear accelerator used to deliver the treatment was supplied by Elekta Limited.  The company’s Steve Bellchambers said: “The Nottingham radiotherapy centre has chosen to use Elekta’s most advanced linear accelerator, which is capable of delivering exquisite dose distributions to the tumour target, while sparing normal tissue.”

See the full report on page 28 of the February 2018 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more